Literature DB >> 25287903

Effects of partial inhibition of respiratory complex I on H2O 2 production by isolated brain mitochondria in different respiratory states.

Luiz G B Michelini1, Carlos E Benevento, Franco A Rossato, Edilene S Siqueira-Santos, Roger F Castilho.   

Abstract

The aim of this work was to characterize the effects of partial inhibition of respiratory complex I by rotenone on H2O2 production by isolated rat brain mitochondria in different respiratory states. Flow cytometric analysis of membrane potential in isolated mitochondria indicated that rotenone leads to uniform respiratory inhibition when added to a suspension of mitochondria. When mitochondria were incubated in the presence of a low concentration of rotenone (10 nm) and NADH-linked substrates, oxygen consumption was reduced from 45.9 ± 1.0 to 26.4 ± 2.6 nmol O2 mg(-1) min(-1) and from 7.8 ± 0.3 to 6.3 ± 0.3 nmol O2 mg(-1) min(-1) in respiratory states 3 (ADP-stimulated respiration) and 4 (resting respiration), respectively. Under these conditions, mitochondrial H2O2 production was stimulated from 12.2 ± 1.1 to 21.0 ± 1.2 pmol H2O2 mg(-1) min(-1) and 56.5 ± 4.7 to 95.0 ± 11.1 pmol H2O2 mg(-1) min(-1) in respiratory states 3 and 4, respectively. Similar results were observed when comparing mitochondrial preparations enriched with synaptic or nonsynaptic mitochondria or when 1-methyl-4-phenylpyridinium ion (MPP(+)) was used as a respiratory complex I inhibitor. Rotenone-stimulated H2O2 production in respiratory states 3 and 4 was associated with a high reduction state of endogenous nicotinamide nucleotides. In succinate-supported mitochondrial respiration, where most of the mitochondrial H2O2 production relies on electron backflow from complex II to complex I, low rotenone concentrations inhibited H2O2 production. Rotenone had no effect on mitochondrial elimination of micromolar concentrations of H2O2. The present results support the conclusion that partial complex I inhibition may result in mitochondrial energy crisis and oxidative stress, the former being predominant under oxidative phosphorylation and the latter under resting respiration conditions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25287903     DOI: 10.1007/s11064-014-1446-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  74 in total

1.  Protective effect of melatonin on rotenone plus Ca2+-induced mitochondrial oxidative stress and PC12 cell death.

Authors:  Solange C Sousa; Roger F Castilho
Journal:  Antioxid Redox Signal       Date:  2005 Sep-Oct       Impact factor: 8.401

2.  Characterization of phosphate efflux pathways in rat liver mitochondria.

Authors:  R S Kaplan; P L Pedersen
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

Review 3.  Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.

Authors:  Rita Perfeito; Teresa Cunha-Oliveira; Ana Cristina Rego
Journal:  Free Radic Biol Med       Date:  2013-06-03       Impact factor: 7.376

4.  Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.

Authors:  A H Schapira; V M Mann; J M Cooper; D Dexter; S E Daniel; P Jenner; J B Clark; C D Marsden
Journal:  J Neurochem       Date:  1990-12       Impact factor: 5.372

5.  MPTP, MPP+ and mitochondrial function.

Authors:  W J Nicklas; S K Youngster; M V Kindt; R E Heikkila
Journal:  Life Sci       Date:  1987-02-23       Impact factor: 5.037

6.  An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.

Authors:  Todd B Sherer; Ranjita Betarbet; Amy K Stout; Serena Lund; Melisa Baptista; Alexander V Panov; Mark R Cookson; J Timothy Greenamyre
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

Review 7.  Lessons from the rotenone model of Parkinson's disease.

Authors:  J Timothy Greenamyre; Jason R Cannon; Robert Drolet; Pier-Giorgio Mastroberardino
Journal:  Trends Pharmacol Sci       Date:  2010-01-22       Impact factor: 14.819

Review 8.  The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.

Authors:  S Fahn; G Cohen
Journal:  Ann Neurol       Date:  1992-12       Impact factor: 10.422

9.  Respiration-dependent removal of exogenous H2O2 in brain mitochondria: inhibition by Ca2+.

Authors:  Franco Zoccarato; Lucia Cavallini; Adolfo Alexandre
Journal:  J Biol Chem       Date:  2003-11-20       Impact factor: 5.157

Review 10.  MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.

Authors:  M Gerlach; P Riederer; H Przuntek; M B Youdim
Journal:  Eur J Pharmacol       Date:  1991-12-12       Impact factor: 4.432

View more
  2 in total

1.  The Effect of Aging on Mitochondrial Complex I and the Extent of Oxidative Stress in the Rat Brain Cortex.

Authors:  Zuzana Tatarkova; Maria Kovalska; Veronika Timkova; Peter Racay; Jan Lehotsky; Peter Kaplan
Journal:  Neurochem Res       Date:  2016-05-09       Impact factor: 3.996

2.  High Doses of Pesticides Induce mtDNA Damage in Intact Mitochondria of Potato In Vitro and Do Not Impact on mtDNA Integrity of Mitochondria of Shoots and Tubers under In Vivo Exposure.

Authors:  Alina A Alimova; Vadim V Sitnikov; Daniil I Pogorelov; Olga N Boyko; Inna Y Vitkalova; Artem P Gureev; Vasily N Popov
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.